|
|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Alliance Entertainment Delivers 259% EBITDA Surge and Double-Digit Revenue Growth in Q1 FY26
Alliance Entertainment (Nasdaq: AENT) posted a standout Q1 FY26 with revenue up 11% to $254M, driven by 59% growth in physical movie sales and a 32% jump in collectibles. Adjusted EBITDA soared 259% to $12.2M, while net income climbed to $4.9M, fueled by margin expansion, AI-powered efficiencies, and rising demand for exclusive content across its 35,000+ retail and e-commerce partners.
|
|
|
|
XTI Aerospace Acquires Drone Nerds, Secures $25M Strategic Investment to Accelerate U.S. Drone Leadership
XTI Aerospace (Nasdaq: XTIA) has acquired Drone Nerds—one of the largest U.S. drone distributors with $100M+ in 2024 revenue—and closed a $25M strategic investment from Unusual Machines (Nasdaq: UMAC), bolstering its push into unmanned systems and vertical flight. The deal expands XTI’s revenue base and operational footprint, positioning the company at the forefront of domestic drone innovation amid rising U.S. demand for secure, high-performance UAV solutions.
|
|
|
|
|
Bimergen Energy Partners with Eos Energy to Power Nearly 8 GWh of U.S. Battery Storage Projects
Bimergen Energy (OTCQB: BESS) has signed a Joint Development Agreement with Eos Energy (Nasdaq: EOSE), aligning its 8 GWh pipeline with Eos’ U.S.-made Z3™ zinc battery technology to accelerate long-duration storage deployment across major U.S. markets. Backed by $250M in project-level capital, the partnership targets near-term ERCOT projects totaling 1 GWh, reinforcing Bimergen’s role in advancing grid reliability and American energy independence.
|
|
|
|
|
|
|
BullFrog AI Spotlights bfPREP™ at AI Drug Discovery Summit in Boston
BullFrog AI (Nasdaq: BFRG) is set to present its bfPREP™ platform at the AI Drug Discovery & Development Summit 2025, showcasing how its human-in-the-loop AI workflows are driving real-world impact in pharmaceutical data preparation. The session will highlight bfPREP™’s role in automating and standardizing clinical and omics data, critical for accelerating analytics and decision-making across the $1+ trillion global biopharma industry.
|
|
|
|
|
New Era Lays Capital-Efficient Foundation for Multi-Gigawatt AI Infrastructure Growth
New Era Energy & Digital (Nasdaq: NUAI) reported Q3 2025 results that reflect its strategic shift from legacy energy operations to building a vertically integrated AI infrastructure platform. With development investments accelerating and legacy revenues winding down, the company is laying the groundwork for a multi-gigawatt platform designed to power the next generation of hyperscale AI demand.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Connect Biopharma Holdings Limited (NASDAQ: CNTB) & Bimergen Energy (OTCQB: BESS)
|
|
|
|
|
|
|
|
|
|
Unlock Smarter Investing with RedChat
|
|
|
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
|
|
Access RedChat now, free of charge.
|
|
|
|
|
Recent Research Coverage Updates

| Company |
Rating |
Price Target |
Firm |
Report Date |
| Nova Minerals (Nasdaq: NVA) |
Buy |
$50 |
ThinkEquity |
October 27, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$15 |
Maxim |
October 15, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$8 |
H.C. Wainwright |
September 22, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
October 6, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$4 |
Maxim |
September 22, 2025 |
| XORTX Therapeutics (Nasdaq: XRTX) |
Buy |
$14 |
AGP |
September 18, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$10 |
H.C. Wainwright |
September 12, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
September 11, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
September 10, 2025 |
| Greenwich LifeSciences (Nasdaq: GLSI) |
Buy |
$45 |
Noble |
August 20, 2025 |
| Nexalin Technology (Nasdaq: NXL) |
Buy |
$4 |
Maxim |
August 19, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7 |
HC Waingwright |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 29, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7.5 |
Northland Securities |
July 23, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$4 |
Titan Partners |
July 17, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$5 |
Maxim |
July 10, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7 |
H.C. Wainwright |
July 9, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 9, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$4 |
HC Wainwright |
July 2, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
July 1, 2025 |
|

|
|
|
|
|
Small Stocks, Big Money™ Podcast
|
|
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
Available on:
|
|
|
|
|
|
|
Upcoming Events
|
|
|
ProPhase Labs (NASDAQ: PRPH)
04:15pm Eastern
ProPhase Labs Inc. (Nasdaq: PRPH) ("ProPhase") is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight.
|
|
|
|
Calidi Biotherapeutics (NYSE American: CLDI)
4:15pm Eastern
RedTail platform precisely delivers genetic medicines to sites of disease, offering solutions from cancer to other complex diseases.
|
|
|
|
Archived Events
|
|
|
Bimergen Energy (OTCQB: BESS)
4:15pm Eastern
Bimergen Energy Corporation is a publicly traded independent power provider and project developer focused on utility-scale battery energy storage systems (BESS) assets.
|
|
|
|
Quote of the Week
|
" The older I get, the more I see a straight path where I want to go. If you're going to hunt elephants, don't get off the trail for a rabbit. "
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Wall Street analysts are wrong more than they are right.
|
|
|
|
|
|
|